JCX-8-23 (May 09, 2023)

Present Law And Economic Background Relating To Pharmaceutical Manufacturers And U.S. International Tax Policy

The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.”  The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.

 

Related Publications

  • JCX-23-25 (May 13, 2025)

    Distribution Of The Estimated Revenue Effects Of The Tax Provisions Of The Chairman's Amendment In The Nature Of A Substitute To The Budget Reconciliation Legislative Recommendations Related to Tax

    view details
  • JCX-22-25R (May 13, 2025)

    Estimated Revenue Effects Of Provisions To Provide For Reconciliation Of The Fiscal Year 2025 Budget

    view details
  • JCX-21-25 (May 12, 2025)

    Description Of The Tax Provisions Of The Chairman’s Amendment In The Nature Of A Substitute To The Budget Reconciliation Legislative Recommendations Related To Tax

    view details